Risk Factors Leading to Enucleation or Evisceration in Infectious Endophthalmitis
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sadiq, M.A.; Hassan, M.; Agarwal, A.; Sarwar, S.; Toufeeq, S.; Soliman, M.K.; Hanout, M.; Sepah, Y.J.; Do, D.V.; Nguyen, Q.D. Endogenous Endophthalmitis: Diagnosis, Management, and Prognosis. J. Ophthalmic Inflamm. Infect. 2015, 5, 32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dave, T.V.; Dave, V.P.; Sharma, S.; Karolia, R.; Joseph, J.; Pathengay, A.; Pappuru, R.R.; Das, T. Infectious Endophthalmitis Leading to Evisceration: Spectrum of Bacterial and Fungal Pathogens and Antibacterial Susceptibility Profile. J. Ophthalmic Inflamm. Infect. 2019, 9, 9. [Google Scholar] [CrossRef] [PubMed]
- Mirzania, D.; Fleming, T.L.; Robbins, C.B.; Feng, H.L.; Fekrat, S. Time to Presentation after Symptom Onset in Endophthalmitis: Clinical Features and Visual Outcomes. Ophthalmol. Retin. 2021, 5, 324–329. [Google Scholar] [CrossRef] [PubMed]
- Relhan, N.; Forster, R.K.; Flynn, H.W. Endophthalmitis: Then and Now. Am. J. Ophthalmol. 2018, 187, xx–xxvii. [Google Scholar] [CrossRef]
- Gao, Z.; Zhang, Y.; Gao, X.; Zhang, X.; Ma, T.; Li, G.; Wang, J.; Yan, H. Clinical Analysis and Predictive Factors Associated with Improved Visual Acuity of Infectious Endophthalmitis. BMC Ophthalmol. 2020, 20, 256. [Google Scholar] [CrossRef]
- Grandi, G.; Bianco, G.; Boattini, M.; Scalabrin, S.; Iannaccone, M.; Fea, A.; Cavallo, R.; Costa, C. Bacterial Etiology and Antimicrobial Resistance Trends in Ocular Infections: A 30-Year Study, Turin Area, Italy. Eur. J. Ophthalmol. 2021, 31, 405–414. [Google Scholar] [CrossRef]
- Lin, L.; Mei, F.; Liao, J.; Yang, Y.; Duan, F.; Lin, X. Nine-Year Analysis of Isolated Pathogens and Antibiotic Susceptibilities of Infectious Endophthalmitis from a Large Referral Eye Center in Southern China. Infect. Drug Resist. 2020, 13, 493–500. [Google Scholar] [CrossRef] [Green Version]
- Henry, C.R.; Flynn, H.W.; Miller, D.; Forster, R.K.; Alfonso, E.C. Infectious Keratitis Progressing to Endophthalmitis. Ophthalmology 2012, 119, 2443–2449. [Google Scholar] [CrossRef] [Green Version]
- Lu, X.; Ng, D.S.C.; Zheng, K.; Peng, K.; Jin, C.; Xia, H.; Chen, W.; Chen, H. Risk Factors for Endophthalmitis Requiring Evisceration or Enucleation. Sci. Rep. 2016, 6, 28100. [Google Scholar] [CrossRef] [Green Version]
- Moshfeghi, D.M.; Moshfeghi, A.A.; Finger, P.T. Enucleation. Surv. Ophthalmol. 2000, 44, 277–301. [Google Scholar] [CrossRef]
- Malihi, M.; Li, X.; Patel, S.; Eck, T.; Chu, D.S.; Zarbin, M.A.; Bhagat, N. Infectious Keratitis-Associated Endophthalmitis: A 14-Year Study. Retina 2017, 37, 662–666. [Google Scholar] [CrossRef] [PubMed]
- O’Neill, E.C.; Yeoh, J.; Fabinyi, D.C.A.; Cassidy, D.; Vajpayee, R.B.; Allen, P.; Connell, P.P. Risk Factors, Microbial Profiles and Prognosis of Microbial Keratitis-Associated Endophthalmitis in High-Risk Eyes. Graefe’s Arch. Clin. Exp. Ophthalmol. 2014, 252, 1457–1462. [Google Scholar] [CrossRef] [PubMed]
- Yang, X.B.; Liu, Y.Y.; Huang, Z.X.; Mao, Y.; Zhao, L.; Xu, Z.P. Clinical Analysis of 1593 Patients with Infectious Endophthalmitis: A 12-Year Study at a Tertiary Referral Center in Western China. Chin. Med. J. 2018, 131, 1658–1665. [Google Scholar] [CrossRef] [PubMed]
- Scott, I.U.; Flynn, J.; Feuer, W.; Pflugfelder, S.C.; Alfonso, E.C.; Forster, R.K.; Miller, D. Endophthalmitis Associated with Microbial Keratitis. Ophthalmology 1996, 103, 1864–1870. [Google Scholar] [CrossRef]
- Ramakrishnan, R.; Bharathi, M.J.; Shivkumar, C.; Mittal, S.; Meenakshi, R.; Khadeer, M.A.; Avasthi, A. Microbiological Profile of Culture-Proven Cases of Exogenous and Endogenous Endophthalmitis: A 10-Year Retrospective Study. Eye 2009, 23, 945–956. [Google Scholar] [CrossRef] [Green Version]
- Lin, C.P.; Shih, M.H.; Tsai, M.C. Clinical Experiences of Infectious Scleral Ulceration: A Complication of Pterygium Operation. Br. J. Ophthalmol. 1997, 81, 980–983. [Google Scholar] [CrossRef]
- Miller, F.C.; Coburn, P.S.; Huzzatul, M.M.; LaGrow, A.L.; Livingston, E.; Callegan, M.C. Targets of Immunomodulation in Bacterial Endophthalmitis. Prog. Retin. Eye Res. 2019, 73, 100763. [Google Scholar] [CrossRef]
- Yannuzzi, N.A.; Si, N.; Relhan, N.; Kuriyan, A.E.; Albini, T.A.; Berrocal, A.M.; Davis, J.L.; Smiddy, W.E.; Townsend, J.; Miller, D.; et al. Endophthalmitis After Clear Corneal Cataract Surgery: Outcomes Over Two Decades. Am. J. Ophthalmol. 2017, 174, 155–159. [Google Scholar] [CrossRef] [Green Version]
- Durand, M.L. Bacterial and Fungal Endophthalmitis. Clin. Microbiol. Rev. 2017, 30, 597–613. [Google Scholar] [CrossRef] [Green Version]
- Kernt, M.; Kampik, A. Endophthalmitis: Pathogenesis, Clinical Presentation, Management, and Perspectives. Clin. Ophthalmol. 2010, 4, 121–135. [Google Scholar] [CrossRef]
- Ciulla, T.A.; Starr, M.B.; Masket, S. Bacterial Endophthalmitis Prophylaxis for Cataract Surgery: An Evidence-Based Update. Ophthalmology 2002, 109, 13–24. [Google Scholar] [CrossRef]
- Chen, K.J.; Chen, Y.P.; Chao, A.N.; Wang, N.K.; Wu, W.C.; Lai, C.C.; Chen, T.L. Prevention of Evisceration or Enucleation in Endogenous Bacterial Panophthalmitis with No Light Perception and Scleral Abscess. PLoS ONE 2017, 12, e0169603. [Google Scholar] [CrossRef] [PubMed]
- Ang, M.; Jap, A.; Chee, S.P. Prognostic Factors and Outcomes in Endogenous Klebsiella Pneumoniae Endophthalmitis. Am. J. Ophthalmol. 2011, 151, 338–344.e2. [Google Scholar] [CrossRef] [PubMed]
- Pappuru, R.R.; Dave, V.P.; Pathengay, A.; Gangakhedkar, S.; Sharma, S.; Narayanan, R.; Tyagi, M.; Grzybowski, A.; Das, T. Endophthalmitis Progressing to Panophthalmitis: Clinical Features, Demographic Profile, and Factors Predicting Outcome. Semin. Ophthalmol. 2018, 33, 671–674. [Google Scholar] [CrossRef]
- Tuazon, C.U.; Murray, H.W.; Levy, C.; Solny, M.N.; Curtin, J.A.; Sheagren, J.N. Serious Infections from Bacillus Sp. JAMA 1979, 241, 1137–1140. [Google Scholar] [CrossRef]
- Davenport, R.; Smith, C. Panophthalmitis Due to an Subtilis Group Organism of the Bacillus subtilis Group. Br. J. Ophthalmol. 1952, 36, 389–392. [Google Scholar] [CrossRef] [Green Version]
- Arora, R.; Das, S.; Chauhan, D.; Daraius, S.; Narula, R.; Sachdev, R. Bilateral Endogenous Panophthalmitis Caused by Salmonella Typhi: First Case Report. Orbit 2008, 27, 115–117. [Google Scholar] [CrossRef]
- Krėpštė, L.; Žemaitienė, R.; Barzdžiukas, V.; Miliauskas, A. Bilateral Endogenous Bacterial Panophthalmitis. Medicina 2013, 49, 143–147. [Google Scholar] [CrossRef]
- Havens, S.J.; Hruby, P.M.; Margalit, E. Listeria Monocytogenes Panophthalmitis: A Novel Strain Follows a Virulent Course. Retin. Cases Br. Rep. 2013, 7, 409–411. [Google Scholar] [CrossRef]
- Papakostas, T.D.; Lee, N.G.; Lefebvre, D.R.; Barshak, M.B.; Freitag, S.K. Endogenous Panophthalmitis with Orbital Cellulitis Secondary to Escherichia Coli. Clin. Exp. Ophthalmol. 2013, 41, 716–718. [Google Scholar] [CrossRef]
- Young, E.J.; Wallace, R.J.J.; Ericsson, C.D.; Harris, R.A.; Clarridge, J. Panophthalmitis Due to Bacillus cereus. Arch. Intern. Med. 1980, 140, 559–560. [Google Scholar] [CrossRef] [PubMed]
- Qi, M.; He, L.; Zheng, P.; Shi, X. Clinical Features and Mortality of Endogenous Panophthalmitis in China: A Six-Year Study. Semin. Ophthalmol. 2021, 37, 208–214. [Google Scholar] [CrossRef] [PubMed]
- Gounder, P.A.; Hille, D.M.; Khoo, Y.J.; Phagura, R.S.; Chen, F.K. ENDOGENOUS ENDOPHTHALMITIS IN WESTERN AUSTRALIA: A Sixteen-Year Retrospective Study. Retina 2020, 40, 908–918. [Google Scholar] [CrossRef] [PubMed]
Number of patients (n) | 69 |
Median age (y) | 70 (range, 10–95) |
Gender (%) | |
Female | 40.58% |
Male | 59.42% |
Past Medical History (%) | |
Diabetes | 62.32% |
Immunosuppressed state | 4.35% |
IVDA history | 2.90% |
Systemic surgery | 2.90% |
Eye-Specific Characteristics at Presentation (%) | |
Unilateral | 100% |
Right eye affected | 55.07% |
Left eye affected | 44.93% |
Visual Acuity at Presentation (%) | |
NLP | 24.64% |
LP | 27.54% |
HM | 21.74% |
CF or more | 21.74% |
Unable to assess | 4.35% |
Etiology (%) | |
Postsurgical | 37.68% |
Exogenous | 33.33% |
Post-traumatic | 14.49% |
Endogenous | 13.04% |
Unknown etiology | 1.45% |
Presence of panophthalmitis (%) | |
Panophthalmitis | 20.29% |
Outcome (%) | |
Evisceration or enucleation | 46.38% |
Eye conservation | 53.62% |
ENEV | EP | OR | 95% CI | p Value | |
---|---|---|---|---|---|
N | 32 (46.38%) | 37 (53.62%) | |||
Demographic characteristics | |||||
Mean Age | 71.84 | 65.6 | 0.82613–13.826 | 0.071 a | |
Male | 16 (50%) | 25 (67.57%) | 0.485 | 0.161–1.418 | 0.216 b |
Female | 16 (50%) | 12 (32.43%) | |||
Etiology | |||||
Postsurgical | 7 (21.88%) | 19 (51.35%) | 0.271 | 0.0783–0.848 | 0.023 c |
Exogenous | 18 (56.25%) | 5 (13.51%) | 7.946 | 2.273–33.135 | 0.0005 c |
Endogenous | 2 (6.25%) | 7 (18.92%) | 0.291 | 0.027–1.695 | 0.161 b |
Post-traumatic | 5 (15.63%) | 5 (13.51%) | 1.182 | 0.244–5.738 | 1 b |
Past Medical History | |||||
Diabetes | 19 (59.38%) | 24 (64.86%) | 0.794 | 0.267–2.352 | 0.836 b |
Immunosuppressed state | 1 (3.13%) | 2 (5.41%) | 0.553 | 0.009–11.116 | 1 b |
IVDA History | 1 (3.13%) | 1 (2.70%) | 1.098 | 0.014–88.88 | 1 b |
Clinical characteristics | |||||
Time of symptom onset to presentation | |||||
Equal or less than 2 days | 6 (18.75%) | 16 (43.24%) | 0.318 | 0.085–1.058 | 0.066 b |
More than 2 days | 24 (75.00%) | 20 (54.05%) | |||
Visual acuity at presentation | |||||
NLP | 15 (46.88%) | 2 (5.41%) | 17.832 | 3.476–180.530 | 0.00003 b |
LP | 7 (21.88%) | 12 (32.43%) | 0.667 | 0.187–2.232 | 0.642 c |
HM | 4 (12.59%) | 11 (29.73%) | 0.383 | 0.0785–1.517 | 0.1497 b |
CF or better | 3 (9.38%) | 12 (32.43%) | 0.2453 | 0.0397–1.060 | 0.044 b |
Final diagnosis of panophthalmitis or endophthalmitis | |||||
Panophthalmitis | 12 (37.50%) | 2 (5.41%) | 10.15 | 1.967–102.461 | 0.002 b |
Endophthalmitis | 20 (62.50%) | 35 (95.59%) | |||
Culture Information | |||||
Positive culture | 16 (50.00%) | 15 (40.54%) | 1.458 | 0.509–4.239 | 0.586 c |
Bacteria | 16 (50.00%) | 14 (37.84%) | 1.631 | 0.567–4.784 | 0.4396 c |
Fungus | 0 (0.00%) | 1 (2.70%) | 0 | 0.000–45.063 | 1 b |
Gram+ | 10 (31.25%) | 12 (32.43%) | 0.346 | 0.0273–2.701 | 0.3898 b |
Gram− | 5 (15.63%) | 2 (5.41%) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lugo Merly, A.N.; Montalvo Toledo, L.A.; Requejo, G.A.; Meléndez, A.; Álvarez, S.; López, A.; Ríos, R.; Villegas, V.M.; Oliver, A.L. Risk Factors Leading to Enucleation or Evisceration in Infectious Endophthalmitis. J. Clin. Med. 2022, 11, 3145. https://doi.org/10.3390/jcm11113145
Lugo Merly AN, Montalvo Toledo LA, Requejo GA, Meléndez A, Álvarez S, López A, Ríos R, Villegas VM, Oliver AL. Risk Factors Leading to Enucleation or Evisceration in Infectious Endophthalmitis. Journal of Clinical Medicine. 2022; 11(11):3145. https://doi.org/10.3390/jcm11113145
Chicago/Turabian StyleLugo Merly, Ambar N., Lorena A. Montalvo Toledo, Guillermo A. Requejo, Alexander Meléndez, Samuel Álvarez, Andrés López, Radames Ríos, Victor M. Villegas, and Armando L. Oliver. 2022. "Risk Factors Leading to Enucleation or Evisceration in Infectious Endophthalmitis" Journal of Clinical Medicine 11, no. 11: 3145. https://doi.org/10.3390/jcm11113145
APA StyleLugo Merly, A. N., Montalvo Toledo, L. A., Requejo, G. A., Meléndez, A., Álvarez, S., López, A., Ríos, R., Villegas, V. M., & Oliver, A. L. (2022). Risk Factors Leading to Enucleation or Evisceration in Infectious Endophthalmitis. Journal of Clinical Medicine, 11(11), 3145. https://doi.org/10.3390/jcm11113145